A08383 Summary:

BILL NOA08383
 
SAME ASSAME AS S05940
 
SPONSORWoerner
 
COSPNSRBlankenbush, Finch, Magee
 
MLTSPNSR
 
Amd 3306, Pub Health L
 
Relates to substances containing chorionic gonadotropin expressly intended for administration through implants or injection to cattle or other nonhuman species.
Go to top    

A08383 Actions:

BILL NOA08383
 
06/12/2017referred to health
01/03/2018referred to health
06/18/2018reported referred to codes
06/19/2018reported referred to rules
06/20/2018reported
06/20/2018rules report cal.446
06/20/2018substituted by s5940
 S05940 AMEND= VALESKY
 05/08/2017REFERRED TO HEALTH
 05/23/20171ST REPORT CAL.1155
 05/24/20172ND REPORT CAL.
 06/05/2017ADVANCED TO THIRD READING
 06/13/2017PASSED SENATE
 06/13/2017DELIVERED TO ASSEMBLY
 06/13/2017referred to health
 01/03/2018died in assembly
 01/03/2018returned to senate
 01/03/2018REFERRED TO HEALTH
 05/31/20181ST REPORT CAL.1495
 06/04/20182ND REPORT CAL.
 06/05/2018ADVANCED TO THIRD READING
 06/07/2018PASSED SENATE
 06/07/2018DELIVERED TO ASSEMBLY
 06/07/2018referred to health
 06/20/2018substituted for a8383
 06/20/2018ordered to third reading rules cal.446
 06/20/2018passed assembly
 06/20/2018returned to senate
 12/12/2018DELIVERED TO GOVERNOR
 12/21/2018SIGNED CHAP.428
Go to top

A08383 Committee Votes:

HEALTH Chair:Gottfried DATE:06/18/2018AYE/NAY:24/0 Action: Favorable refer to committee Codes
GottfriedAyeRaiaAye
SchimmingerAyeMcDonoughAye
GalefAyeRaAye
DinowitzAyeWalterAye
CahillAyeGarbarinoAye
PaulinAyeByrneAye
CymbrowitzAyeNorrisAye
GuntherAye
RosenthalAye
HevesiAye
LavineExcused
TitoneAye
JaffeeAye
SteckAye
AbinantiAye
BraunsteinAye
KimExcused
SolagesAye
BichotteAye

CODES Chair:Lentol DATE:06/19/2018AYE/NAY:20/0 Action: Favorable refer to committee Rules
LentolAyeCurranAye
SchimmingerAyeGiglioAye
PretlowAyeMontesanoAye
CookAyeMorinelloAye
CymbrowitzAyePalumboAye
TitusAbsentGarbarinoAye
O'DonnellAbsent
LavineAye
PerryAye
ZebrowskiAye
AbinantiAye
WeprinAye
MosleyAye
HevesiAye
FahyAye
SeawrightAye

RULES Chair:Gottfried DATE:06/20/2018AYE/NAY:27/0 Action: Favorable
HeastieExcusedKolbAye
GottfriedAyeOaksAye
LentolAyeButlerAye
GanttExcusedCrouchAye
NolanAyeFinchAye
WeinsteinAyeBarclayAye
HooperAyeRaiaAye
OrtizAyeHawleyAye
PretlowAye
CookAye
GlickAye
MorelleAye
AubryAye
EnglebrightAye
DinowitzAye
ColtonAye
MagnarelliAye
PerryExcused
GalefAye
PaulinAye
TitusExcused
Peoples-StokesAye
BenedettoAye

Go to top

A08383 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

A08383 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A8383
 
SPONSOR: Woerner
  TITLE OF BILL: An act to amend the public health law, in relation to substances containing chorionic gonadotropin   PURPOSE OR GENERAL IDEA OF BILL: To relieve veterinarians from the unnecessary burden associated with complying with controlled substance requirements for the use veterinary use of hCG. This bill mirrors current language that exempts formulations for animals containing anabolic steroids under subdivision (i) of sched- ule II of section 3306 of the public health law.   SUMMARY OF SPECIFIC PROVISIONS: Section 1 amends Schedule III of section 3306 of the public health law to exempt substances containing human chorionic gonadotropin (hCG) that are expressly intended for use in animals from the provisions of the controlled substances law. Section 2 takes effect in 180 days after it is signed in to law.   JUSTIFICATION: Human Chorionic Gonadotropin (hCG) is safe and effective when formulated for treating specific reproductive conditions in cattle and fish. This bill will allow veterinarians to have improved access to use such formu- lations to ensure that animals remain healthy and productive. The language in the bill mirrors the existing exemption for products formu- lated for animals containing anabolic steroids. hCG, has been used by athletes and body builders as an agent to improve testosterone production and counteract the negative side effects due to use of anabolic steroids. As a consequence, a number of states, including NY, included hCG on their schedule of controlled substances. However, most states, 44, have exempted hCG containing products formu- lated for use in animals. In fact, US Drug Enforcement Agency does not classify such formulations as controlled substances, meaning it can be sold as a veterinary product without the additional documentation or security requirements associated with controlled substances. This bill does not lesson the penalties for the prescription, distrib- ution or diversion of the hCG containing products for use in humans. It simply seeks to relieve distributors, farmers, and veterinarians from the cost and difficulty associated with handling a product listed under Schedule III.   PRIOR LEGISLATIVE HISTORY: This is a new bill.   FISCAL IMPLICATIONS: None   EFFECTIVE DATE: 180 days after is shall have become law.
Go to top

A08383 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          8383
 
                               2017-2018 Regular Sessions
 
                   IN ASSEMBLY
 
                                      June 12, 2017
                                       ___________
 
        Introduced  by M. of A. WOERNER -- read once and referred to the Commit-
          tee on Health
 
        AN ACT to amend  the  public  health  law,  in  relation  to  substances
          containing chorionic gonadotropin
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Subdivision (g) of schedule III  of  section  3306  of  the
     2  public  health  law,  as  amended by chapter 457 of the laws of 2006, is
     3  amended to read as follow:
     4    (g) Chorionic gonadotropin. (1) Unless specifically excepted or unless
     5  listed in another schedule any material, compound, mixture, or  prepara-
     6  tion which contains any amount of chorionic gonadotropin.
     7    (2)  Paragraph one of this subdivision shall not include any substance
     8  containing chorionic gonadotropin expressly intended for  administration
     9  through  implants  or  injection to cattle or other nonhuman species and
    10  that are approved by the federal food and drug administration solely for
    11  such use. Any individual who  knowingly  and  willfully  administers  to
    12  himself  or  another  person,  prescribes, dispenses or distributes such
    13  substances for other than implantation or injection to cattle or  nonhu-
    14  man species shall be subject to the same penalties as a practitioner who
    15  violates   the  provisions  of  this  section  or  any  other  penalties
    16  prescribed by law.
    17    § 2. This act shall take effect on the one hundred eightieth day after
    18  it shall have become a law.
 
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD11462-01-7
Go to top